317 related articles for article (PubMed ID: 8528560)
1. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
3. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
4. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
5. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of GYKI-46 903, a non-competitive ligand at 5-HT3 receptors.
Vitális B; Sebestyén L; Sike M; Sólyom S; Hársing LG
Pharmacol Res; 2001 Mar; 43(3):291-9. PubMed ID: 11401422
[TBL] [Abstract][Full Text] [Related]
7. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
8. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
Fletcher S; Barnes NM
Br J Pharmacol; 1997 Oct; 122(4):655-62. PubMed ID: 9375961
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
Parker RM; Barnes JM; Ge J; Barber PC; Barnes NM
J Neurol Sci; 1996 Dec; 144(1-2):119-27. PubMed ID: 8994113
[TBL] [Abstract][Full Text] [Related]
10. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
[TBL] [Abstract][Full Text] [Related]
12. Different densities of 5-HT3 receptors are labeled by [3H]quipazine, [3H]GR 65630 and [3H]granisetron.
Wong EH; Bonhaus DW; Lee JA; Wu I; Loury DN; Eglen RM
Neuropharmacology; 1993 Sep; 32(9):869-75. PubMed ID: 8232790
[TBL] [Abstract][Full Text] [Related]
13. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
[TBL] [Abstract][Full Text] [Related]
14. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
Ge J; Barnes JM; Towers P; Barnes NM
Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
[TBL] [Abstract][Full Text] [Related]
15. A pharmacological comparison of [3H]-granisetron binding sites in brain and peripheral tissues of the mouse.
Perren MJ; Rogers H; Mason GS; Bull DR; Kilpatrick GJ
Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):221-8. PubMed ID: 7609774
[TBL] [Abstract][Full Text] [Related]
16. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584.
Miller K; Weisberg E; Fletcher PW; Teitler M
Synapse; 1992 May; 11(1):58-66. PubMed ID: 1318585
[TBL] [Abstract][Full Text] [Related]
18. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
20. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
